Invesco Ltd. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$9,177,321
+2040.6%
239,055
+957.8%
0.00%
Q2 2023$428,722
+72.4%
22,600
+40.9%
0.00%
Q1 2023$248,734
-16.9%
16,037
-4.9%
0.00%
Q4 2022$299,301
+236.3%
16,862
+5.2%
0.00%
Q3 2022$89,000
+41.3%
16,034
-1.3%
0.00%
Q2 2022$63,000
-38.8%
16,243
-13.1%
0.00%
Q1 2022$103,000
-32.7%
18,700
+4.0%
0.00%
Q4 2021$153,000
-15.9%
17,989
-14.0%
0.00%
Q3 2021$182,000
-98.0%
20,924
-97.6%
0.00%
-100.0%
Q2 2021$9,111,000
-33.9%
862,013
+0.3%
0.00%
-50.0%
Q1 2021$13,792,000
-73.5%
859,862
-23.7%
0.00%
-73.3%
Q4 2020$52,078,000
+505.0%
1,127,487
+360.9%
0.02%
+400.0%
Q3 2020$8,608,000
+135.9%
244,625
+63.2%
0.00%
+200.0%
Q2 2020$3,649,000149,8490.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders